Congress Turns Up Heat For More Information On FDA Performance, Funding

During a Jan. 29 hearing on FDA's "Science and Mission at Risk" FDA Commissioner Andrew von Eschenbach told a House subcommittee the agency is fulfilling its responsibilities, but acknowledged additional funding and other resources are needed